The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Cancer survival: global surveillance will stimulate health policy and improve equity
Abstract
Millions of people will continue to be diagnosed with cancer every year for the foreseeable future. These patients all need access to optimum health care. Population-based cancer survival is a key measure of the overall effectiveness of health systems in management of cancer. Survival varies very widely around the world. Global surveillance of cancer survival is needed, because unless these avoidable inequalities are measured, and reported on regularly, nothing will be done explicitly to reduce them.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Population-based cancer survival is increasingly recognised as a key indicator of the overall effectiveness of the health systems in managing care and treatment for all cancer patients.46,47”
In the citing paper
“Achieving the SDG target of a one-third reduction in premature mortality by 2030 clearly requires more effective prevention, to reduce cancer incidence. However, the 15-year time-frame is short, and achieving the target will also require investment in more effective health systems, to improve survival.46”
Citations
Cites
Jemal, A., Bray, F., Ferlay, J., Ward, E., & Forman, D. (2011) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 55,077
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
Vos, T., Flaxman, A. D., Naghavi, M., Lozano, R., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., Aboyans, V., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61729-2 · Cited by 8,291
Bray, F., Jemal, A., Grey, N., Ferlay, J., & Forman, D. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70211-5 · Cited by 2,225
Recent cancer survival in Europe: a 2000–02 period analysis of EUROCARE-4 data
Verdecchia, A., Francisci, S., Brenner, H., Gatta, G., Micheli, A., Mangone, L., & Kunkler, I. H. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70246-2 · Cited by 1,285
Coleman, M. P., Forman, D., Bryant, H., Butler, J., Rachet, B., Maringe, C., Nur, U., Tracey, E. A., Coory, M. D., Hatcher, J., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)62231-3 · Cited by 1,114
Self-citationOrigins of socio-economic inequalities in cancer survival: a review
Woods, L. M., Rachet, B., & Coleman, M. P. (2005) · Annals of Oncology · doi:10.1093/annonc/mdj007 · Cited by 1,101
Self-citationEUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary
Sant, M., Allemani, C., Santaquilani, M., Knijn, A., Marchesi, F., & Capocaccia, R. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.11.018 · Cited by 1,020
EUROCARE-3: survival of cancer patients diagnosed 1990–94—results and commentary
Sant, M., Aareleid, T., Berrino, F., Lasota, M. B., Carli, P., Faivre, J., Grosclaude, P., Hédelin, G., Matsuda, T., Møller, H., et al. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg754 · Cited by 1,010
Cancer survival in five continents: a worldwide population-based study (CONCORD)
Coleman, M. P., Quaresma, M., Berrino, F., Lutz, J.-M., De Angelis, R., Capocaccia, R., Baili, P., Rachet, B., Gatta, G., Hakulinen, T., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70179-7 · Cited by 1,002
Self-citation
Research works printed but not linked: 2
- 2010, World Cancer Declaration, UICC
- Beniaiche, 2012, La déficience de notre système de santé est à l'origine du taux de survie si bas [in French], El Watan [Algeria]
Cited by
Sorted by citations
Fitzmaurice, C., Allen, C., Barber, R. M., Barregård, L., Bhutta, Z. A., Brenner, H., Dicker, D., Chimed‐Ochir, O., Dandona, R., Dandona, L., et al. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.5688 · Cited by 6,318
Allemani, C., Matsuda, T., Di Carlo, V., Harewood, R., Matz, M., Nikšić, M., Bonaventure, A., Valkov, M., Johnson, C. J., Estève, J., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)33326-3 · Cited by 6,145
Self-citationAllemani, C., Weir, H. K., Carreira, H., Harewood, R., Spika, D., Wang, X.-S., Bannon, F., Ahn, J. V., Johnson, C. J., Bonaventure, A., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62038-9 · Cited by 2,614
Self-citationZeng, H., Chen, W., Zheng, R., Zhang, S., Ji, J. S., Zou, X., Xia, C., Sun, K., Yang, Z., Li, H., et al. (2018) · The Lancet Global Health · doi:10.1016/s2214-109x(18)30127-x · Cited by 1,558
Curigliano, G., Lenihan, D., Fradley, M., Ganatra, S., Barac, A., Blaes, A., Herrmann, J., Porter, C., Lyon, A. R., Lancellotti, P., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2019.10.023 · Cited by 1,031
Metadata
- Authors
- Coleman, M. P.
- Affiliations
- Cancer Research UK (GB)
- Corresponding author
- Coleman, Michel P
- ORCID
- Coleman, Michel P
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2014-02
- Volume
- 383
- Issue
- 9916
- Pages
- 564-573
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2057721627
- Cited by
- 370
- References
- 72
- Citations by year
- 2026: 13 · 2025: 12 · 2024: 8 · 2023: 8 · 2022: 13 · 2021: 13 · 2020: 222 · 2019: 14 · 2018: 18 · 2017: 16 · 2016: 16 · 2015: 9 · 2014: 7
- FWCI
- 1.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (submittedVersion)
- Funders
- Cancer Research UK (11700, 16148)
- Topics
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Economic and Financial Impacts of Cancer
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advances in Oncology and Radiotherapy
- Keywords
- cancer survival, health equity, health policy, access to cancer care, health system effectiveness, cancer epidemiology
- MeSH terms
- Adult, Aged, Health Planning, Health Policy, Health Services Accessibility, Humans, International Cooperation, Middle Aged, Neoplasms, Global Health, Survival Analysis, Cost of Illness, Healthcare Disparities, Mortality, Premature, Public Health Surveillance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
